6.
Murphy T, Brauer A, Eschberger K, Lobbins P, Grove L, Cai X
. Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008; 177(8):853-60.
DOI: 10.1164/rccm.200709-1413OC.
View
7.
Fischer A, Singh S, LaMarche M, Maakestad L, Kienenberger Z, Pena T
. Sustained Coinfections with and in Cystic Fibrosis. Am J Respir Crit Care Med. 2020; 203(3):328-338.
PMC: 7874317.
DOI: 10.1164/rccm.202004-1322OC.
View
8.
Willner D, Hugenholtz P, Yerkovich S, Tan M, Daly J, Lachner N
. Reestablishment of recipient-associated microbiota in the lung allograft is linked to reduced risk of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 2013; 187(6):640-7.
DOI: 10.1164/rccm.201209-1680OC.
View
9.
Neff S, Hampton T, Puerner C, Cengher L, Doing G, Lee A
. CF-Seq, an accessible web application for rapid re-analysis of cystic fibrosis pathogen RNA sequencing studies. Sci Data. 2022; 9(1):343.
PMC: 9203545.
DOI: 10.1038/s41597-022-01431-1.
View
10.
Erb-Downward J, Thompson D, Han M, Freeman C, McCloskey L, Schmidt L
. Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One. 2011; 6(2):e16384.
PMC: 3043049.
DOI: 10.1371/journal.pone.0016384.
View
11.
Das S, McClain C, Rai S
. Fifteen Years of Gene Set Analysis for High-Throughput Genomic Data: A Review of Statistical Approaches and Future Challenges. Entropy (Basel). 2020; 22(4).
PMC: 7516904.
DOI: 10.3390/e22040427.
View
12.
Oluyombo O, Penfold C, Diggle S
. Competition in Biofilms between Cystic Fibrosis Isolates of Is Shaped by R-Pyocins. mBio. 2019; 10(1).
PMC: 6355985.
DOI: 10.1128/mBio.01828-18.
View
13.
Werner T
. Bioinformatics applications for pathway analysis of microarray data. Curr Opin Biotechnol. 2008; 19(1):50-4.
DOI: 10.1016/j.copbio.2007.11.005.
View
14.
. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020; 8(6):585-596.
PMC: 7284317.
DOI: 10.1016/S2213-2600(20)30105-3.
View
15.
Barrack K, Hampton T, Valls R, Surve S, Gardner T, Sanville J
. An medium for modeling gut dysbiosis associated with cystic fibrosis. J Bacteriol. 2024; 206(1):e0028623.
PMC: 10810206.
DOI: 10.1128/jb.00286-23.
View
16.
Doing G, Koeppen K, Occipinti P, Harty C, Hogan D
. Conditional antagonism in co-cultures of Pseudomonas aeruginosa and Candida albicans: An intersection of ethanol and phosphate signaling distilled from dual-seq transcriptomics. PLoS Genet. 2020; 16(8):e1008783.
PMC: 7480860.
DOI: 10.1371/journal.pgen.1008783.
View
17.
Harris M, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R
. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res. 2003; 32(Database issue):D258-61.
PMC: 308770.
DOI: 10.1093/nar/gkh036.
View
18.
Koeppen K, Stanton B, Hampton T
. ScanGEO: parallel mining of high-throughput gene expression data. Bioinformatics. 2017; 33(21):3500-3501.
PMC: 5860173.
DOI: 10.1093/bioinformatics/btx452.
View
19.
Moreau-Marquis S, Coutermarsh B, Stanton B
. Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells. J Antimicrob Chemother. 2014; 70(1):160-6.
PMC: 4267504.
DOI: 10.1093/jac/dku357.
View
20.
Bouzo D, Cokcetin N, Li L, Ballerin G, Bottomley A, Lazenby J
. Characterizing the Mechanism of Action of an Ancient Antimicrobial, Manuka Honey, against Pseudomonas aeruginosa Using Modern Transcriptomics. mSystems. 2020; 5(3).
PMC: 7329319.
DOI: 10.1128/mSystems.00106-20.
View